NCT05104138

Eplerenone Versus PDT: Comparative Study by OCTA

OCTA in Central Serous Chorioratinopathy Treated With Oral Eplerenone or Hal-fluence Photodynamic Therapy: a Comparative Study

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 30 (actual)
• Sponsor: Federico II University · Academic / Other
• Sex: All
• Age: 30 Years – 60 Years
• Healthy volunteers: —

Summary

The study aims to analyze the changes in OCTA parameters and in choroidal thickness in patients affected by central serous chorioretinopathy treated by oral eplerenone and half-fluence photodynamic therapy.

Detailed description

Central serous chorioretinopathy (CSC) is a chorioretinal disease characterized by serous detachment due to the dilatation and hyperpermeability of choroidal vessels resulting in the accumulation of serous fluid between the neurosensory retina and the retinal pigment epithelium. Several studies reported the efficacy of half-fluence photodynamic therapy (PDT) and oral eplerenone in the CSC treatment inducing a reduction of the choroidal hyperpermeability and remodeling the choroidal vascularization. This retrospective study aims to perform a quantitative analysis of retinal and CC vessel density by OCTA at baseline, 3 and 6 months in patients underwent PDT and patients underwent eplerenone.

Conditions

• Central Serous Chorioretinopathy

Interventions

Type	Name	Description
DRUG	Eplerenone	The patients underwent eplerenone treatment for 6 months
DEVICE	The patients underwent half fluence photodynamic therapy for 6 months	Half fluence photodynamic therapy for 6 months

Timeline

• Start date: 2015-10-01
• Primary completion: 2017-10-30
• Completion: 2017-11-30
• First posted: 2021-11-02
• Last updated: 2021-11-02